Richard William Scalzo

CIK 1789545 · Chief Financial Officer · last filed 2025-12-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.23M

Companies

2

Total Filings

36

Lifetime Open-Market Net

-$8.71M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRESCENT BIOPHARMA, INC. (GLYC) Delisted Chief Financial Officer 19,422 $15.70 $304.9K $0 1 2025-12-17
DYN SVP, Head of Finance & Admin. 122,330 $18.19 $2.23M -$8.71M 35 2025-03-13

Recent Filings · Page 2 of 4

36 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-08-20 DYN Sell (S) −2,752 -$124.2K EDGAR
2024-06-11 DYN Sell (S) −2,921 -$89.8K EDGAR
2024-05-17 DYN Sell (S) −2,588 -$73.2K EDGAR
2024-03-12 DYN Mixed −2,672 -$1.85M EDGAR
2024-03-11 DYN Sell (S) −2,273 -$58.8K EDGAR
2024-03-01 DYN Mixed -$344.2K EDGAR
2024-01-26 DYN Mixed -$303.0K EDGAR
2024-01-04 DYN Mixed -$231.1K EDGAR
2023-12-14 DYN Sell (S) −2,376 -$28.6K EDGAR
2023-12-12 DYN Sell (S) −1,380 -$14.8K EDGAR
Showing 1120 of 36
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.